Renal Function Deterioration After Radical Cystectomy and Analysis of Predictive Factors for Renal Deterioration
Journal Title: Üroonkoloji Bülteni - Year 2017, Vol 16, Issue 2
Abstract
Objective: Renal function deterioration develops in most of the patients treated with radical cystectomy (RC). In this study, we aimed to evaluate the changes in renal function of bladder cancer (BC) patients who had minimum 5 years of follow-up period after RC. Materials and Methods: In this study, 175 patients who underwent RC for BC at our institution between January 1995 and December 2010 were included. Age, gender, baseline glomerular filtration rate (GFR) before RC, tumor histology, pathological tumor stage, comorbidity record and presence of hydronephrosis before treatment were evaluated. GFR was calculated with the modification of diet in renal disease equation. GFR measurements of every 6 months were recorded in the follow-up. Results: The mean age and mean GFR before RC were 66.5±17.9 years and 91.1±18.2 mL/min, respectively. Patients separated into two groups for having ileal conduit diversion and ileal substitution (IS). It was found out that although baseline GFRs were similar for both groups, GFR was significantly lower in patients of RC with IS after the first year of follow-up period. According to multivariate logistic analysis, having IS as a diversion method (p=0.0001, odds ratio (OR): 3.2, 95% confidence interval (CI): 1.248-5.481), presence of diabetes mellitus record (p=0.0001, OR: 4.9, 95% CI: 2.575-9.706) and presence of hypertension record (p=0.0001, OR: 3.6, 95% CI: 2.019-6.552) were found to be associated with decrease in GFR. Conclusion: Renal function deterioration mostly develops in patients after RC surgery within 5 years. Renal function deterioration was more prominent in IS patients who had diabetes mellitus, hypertension record.
Authors and Affiliations
Nurullah Hamidi, Evren Süer, Mete Özkıdık, Uygar Bağcı, İlker Gökçe, Kadir Türkölmez, Yaşar Bedük, Sümer Baltacı
Keywords
Related Articles
- EP ID EP226690
- DOI 10.4274/uob.799
- Views 130
- Downloads 0
What are the New Developments in Urinary, Serum and Tissue Biomarkers in Prostate Cancer?
Currently the accepted screening tools for prostate cancer are prostate specific antigen (PSA) and rectal examination. PSA is specific to prostate, but not to prostate cancer. Therefore, identifying prostate cancer only...
Mycobacterium Brumae Extract Fractions with Potential Immunotherapeutic Activity for Bladder Cancer
Objective: Immunotherapy with intravesical Bacillus Calmette-Guérin (BCG) application is a gold standard treatment for high risk non-muscle invasive bladder cancer (NMIBC), despite its local and systemic side effects. We...
Contemporary Trends in Adjuvant and Neoadjuvant Treatment for Renal Cell Carcinoma
Renal cell carcinoma is an increasingly significant cancer in which surgical resection is still the sole curative approach. There is a risk of recurrence in one-third of patients after surgery. Successful experiences wit...
Incidentally Found Paratesticular Rhabdomyosarcoma: Case Report
Paratesticular rhabdomyosarcomas (RMS) constitute 7% of all RMS. Paratesticular RMS are malignant tumors and although many of them are seen in children and adolescents, 24% of them are seen in adults. A patient in the ol...
Risk Factors for Urothelial Cancers
Urothelial cancers affect renal pelvis and ureters in the upper urinary tract, however they affect bladder and urethra in the lower urinary tract. The rate of the urothelial carcinoma makes up 3% pf cancers in the world....